A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail

Active Cooperative Agreement Awarded Last action

Award ID
UG1DA050077
Recipient
Awarding agency
Obligated
$26,840,495

Award facts

Assistance listing
93.279 Drug Use and Addiction Research Programs
Completion date 93% complete
Originally
Funding
  • $24,559,054.44 Federal
  • $2,281,441.00 Non-federal
Place of performance
Maryland, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment -$245,497 $0
Amendment -$245,497 $0
Amendment $0 $0
Amendment Long-acting naltrexone for pre-release prisoners: a randomized trial of mobile treatment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $444,092 $0
Amendment $444,092 $0
Amendment $444,092 $0
Amendment $1,967,149 $0
Amendment $1,967,149 $0
Amendment Long-acting naltrexone for pre-release prisoners: a randomized trial of mobile treatment $1,967,149 $0
Amendment $678,563 $0
Amendment $678,563 $0
Amendment $678,563 $0
Amendment $678,563 $0
Amendment $2,169,367 $0
Amendment $2,169,367 $0
Amendment $2,169,367 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment A comparison of sublingual and extended-release buprenorphine for individuals leaving jail $0 $0
Amendment $100,000 $0
Amendment $65,428 $0
Amendment $65,428 $65,428
Amendment $2,216,013 $0
Amendment $2,216,013 $2,216,013
Amendment $2,231,473 $0
Amendment $0 $0
Amendment $0 $0
Original award $1,699,618 $0
Show all 41

Subawards

Subrecipient Amount Awarded
University Of Maryland, Baltimore University of Maryland Baltimore (UMB) will conduct an observational trial to assess feasibility (SA1a) and preliminary efficacy (assessed as re-linkage to… $188,465
University Of Maryland, Baltimore Under the proposed subcontract, UMB will serve as study site for project titled: A comparative effectiveness trial of extended release naltrexone versus… $159,629
Glenwood Life-Counseling Center, Inc. Glenwood Life Counseling (GLCC) has been in continuous operation for 41 years. It is a State of Maryland-certified and *CARF-accredited outpatient drug… $30,130
Maryland Treatment Centers, Inc. Co-Investigator and Site-PI (Marc Fishman MD, 5% effort, Years 1-2). Dr. Fisman, who is experienced in substance abuse treatment, will supervise all in jail… $146,896
Weill Medical College Of Cornell University Sean Murphy, PhD (0.6 calendar months, Years 1 & 2). Dr. Murphy will serve as the lead health economist for this project, overseeing all aspects of the economic… $49,893
Weill Medical College Of Cornell University $34,208
Maryland Treatment Centers, Inc. Co-Investigator and Site-PI (Marc Fishman MD, 5% effort, Years 1-2). Dr. Fisman, who is experienced in substance abuse treatment, will supervise all in jail… $85,350

Quick answers

Who received award UG1DA050077?

UG1DA050077 was awarded to Friends Research Institute, Inc. by National Institute on Drug Abuse (National Institutes of Health) on July 15, 2019.

How much is award UG1DA050077 worth?

$26,840,495 has been obligated on UG1DA050077: $24,559,054 in federal funding and $2,281,441 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login